Clinical Trials Directory

Trials / Unknown

UnknownNCT03009643

Salvage Treatment of Inhaled Nitric Oxide in Patients With Refractory Hypoxemia After Aortic Surgery

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Shanghai Zhongshan Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Hypoxemia is a common complication after aortic surgery. As this complication has an adverse effect on the postoperative course of the patient, early treatment is important; however, the mechanism of hypoxemia after surgery for acute aortic dissection remains unclear. Recently, the investigators found that inhaled Nitric Oxide can improve the oxygenation in some of these patients. The investigators are trying to evaluate the effectiveness and safety of inhaled Nitric Oxide in patients with refractory hypoxemia after aortic surgery.

Detailed description

Several risk factors for severe hypoxemia after aortic surgery have been reported including advanced age, obesity, smoking history, previous heart surgery,emergency surgery,reduced cardiac function, advanced chronic obstructive pulmonary disease, excessive volume of blood transfusion,and prolonged CPB time. The routine treatment includes lung protective mechanical ventilation, recruitment maneuvers and glucocorticoids. No previous clinical studies have reported the effectiveness and safety of inhaled Nitric Oxide in patients with refractory hypoxemia after aortic surgery.

Conditions

Interventions

TypeNameDescription
DRUGInhaled Nitric OxidePatients are treated with iNO for 3-5 days.The concentration of inhaled Nitric Oxide is around 5-10ppm.
DEVICElung protective mechanical ventilationMechanical ventilation in the SIMV mode (ventilators Evita 2 or 4,Dräger, Lübeck, Germany) with VT 6-8ml/kg
DEVICEHemodynamic monitoringFlotrac/Vigileo (Edwards Lifesciences) are used to guide the fluid management.

Timeline

Start date
2016-10-01
Primary completion
2019-10-01
Completion
2019-12-01
First posted
2017-01-04
Last updated
2018-02-05

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03009643. Inclusion in this directory is not an endorsement.